Skip to main content

Opaleye Management Inc.'s Form 4 filing

Protara Therapeutics, Inc. (TARA) · filed Dec 29, 2021

Accession no.
0001493152-21-032722
Filed
Dec 29, 2021
Trade date
Dec 28-29, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $76.5K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Opaleye Management Inc.CIK 000159585510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 28, 2021Common Stock, par value $0.001 per sharePPurchaseAcquired+1,591$6.36F3+$10,118.762,530,000Indirect
Dec 28, 2021Common Stock, par value $0.001 per sharePPurchaseAcquired+5,500$6.36F3+$34,980115,500Indirect
Dec 29, 2021Common Stock, par value $0.001 per sharePPurchaseAcquired+4,500$6.98F4+$31,410120,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.3588. The range of purchase prices on the transaction date was $6.24 to $6.49 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Referenced by the price of 2 transactions in Table I.

F4

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $ 6.3172. The range of purchase prices on the transaction date was $6.26 to $6.38 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)